Mesoblast (MESO) Cash from Operations (2016 - 2023)
Mesoblast's (MESO) quarterly Cash from Operations came in at 110260000.0 in Q2 2023, up 6.3% year-on-year from 103727967.7 in Q2 2022, and down 778.52% quarter-over-quarter from 16250000.0 in Q1 2023.
Mesoblast (MESO) Cash from Operations (2016 - 2023) Analysis & Trends
Mesoblast has disclosed Cash from Operations across 8 years of filings, most recently posting 110260000.0 for Q2 2023.
- Cash from Operations for Q2 2023 came in at 110260000.0, up 6.3% year-over-year; the trailing twelve-month figure through Jun 2023 was 63269000.0 (up 38.11% YoY), and the FY2025 annual result was 50000000.0, down 3.18% from the prior year.
- Cash from Operations came in at 110260000.0 for Q2 2023 at Mesoblast, down from 16250000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 139187000.0 in Q1 2021 to a low of 182578000.0 in Q2 2021.
- The 5-year median for Cash from Operations is 7808500.0 (2019), against an average of 21852777.78.
- Across the five-year window, Cash from Operations tumbled 2399.25% in 2020 and surged 599.61% in 2021, its largest moves.
- Mesoblast's Cash from Operations stood at 1330000.0 in 2019, then sank by 2399.25% to 30580000.0 in 2020, then soared by 40.42% to 18219000.0 in 2021, then jumped by 190.31% to 16454000.0 in 2022, then slumped by 770.11% to 110260000.0 in 2023.
- The last three Cash from Operations figures came in at 110260000.0 (Q2 2023), 16250000.0 (Q1 2023), and 16454000.0 (Q4 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mesoblast | 21.68 Bn | 21.55 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | -110.26 Mn |
| Jun 30, 2023 | -110.26 Mn |
| Mar 31, 2023 | 16.25 Mn |
| Mar 31, 2023 | 16.25 Mn |
| Dec 31, 2022 | 16.45 Mn |
| Dec 31, 2022 | 16.45 Mn |
| Sep 30, 2022 | 14.29 Mn |
| Sep 30, 2022 | 14.29 Mn |
| Jun 30, 2022 | -117.67 Mn |
| Jun 30, 2022 | -117.67 Mn |
| Mar 31, 2022 | 15.47 Mn |
| Mar 31, 2022 | 15.47 Mn |
| Dec 31, 2021 | -18.22 Mn |
| Dec 31, 2021 | -18.22 Mn |
| Sep 30, 2021 | 18.20 Mn |
| Sep 30, 2021 | 18.20 Mn |
| Jun 30, 2021 | -182.58 Mn |
| Jun 30, 2021 | -182.58 Mn |
| Mar 31, 2021 | 139.19 Mn |
| Mar 31, 2021 | 139.19 Mn |